La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Intl Tower Hill Mines a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Intl Tower Hill Mines..

Intl Tower Hill Mines (AMEX:THM) Azioni, Catena delle Opzioni

Intl Tower Hill Mines

International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project namely the Livengood Gold Project. It is located in northwest of Fairbanks, Alaska in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.

International Tower Hill Mines, Ltd. Ordinary Shares (Canada)

International Tower Hill Mines Ltd

THUNDER MOUNTAIN GOLD INC by Thunder Mountain Gold, Inc.

Thunder Mountain Gold Inc

THAICOM PUBLIC CO ORD by Thaicom Public Co., Ltd.

THERMOGENESIS HLDGS INC by ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings Inc

Lazard Equity Megatrends ETF

Intl Tower Hill Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/THM#AMEX">THM</a>) will report on Q1 2025.

Earnings

News

Intl Tower Hill Mines Q1 2025 GAAP EPS Nil, Revenue Nil

Billionaire investor John Paulson and NovaGold Resources, Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NG#AMEX">NG</a>) have agreed to purchase a significant stake in the Donlin Gold project in Alaska. Barrick Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>) will sell its entire 50% interest in the project <a href="https://www.benzinga.com/25/04/44927342/novagold-partners-inks-deal-with-barrick-gold-boosts-stake-in-donlin-project-for-1-billion">for $1 billion in cash.</a>
The Details: Novagold will purchase a 10% stake in Donlin Gold for $200 million, raising its ownership to 60% from 50%.
Paulson &amp; Co. will acquire the remaining 40% for $800 million, becoming a full and equal partner in managing the Donlin Gold project.
The Donlin Gold Project is a planned mining operation located in Alaska, with estimated gold reserves of approximately 39 million ounces — making it one of the world's largest undeveloped gold deposits.
Read Next:<a href="https://www.benzinga.com/general/health-care/25/04/44869920/unitedhealth-ceo-says-high-cost-of-us-health-care-simply-not-sustainable"> UnitedHealth CEO Says High Cost Of US Health Care &#8216;Simply Not Sustainable&#8217;&nbsp;</a>
Paulson, who has several notable investments in gold miners, called Donlin Gold "one of the most attractive development gold projects in the world."&nbsp;
"With 39 million ounces of gold at double the industry average grade, and an optimal location in the prime jurisdiction of Alaska — already the second largest gold-producing state in the United States — we believe that the project could create value for decades to come," Paulson added.&nbsp;
Paulson's Gold Miners: The billionaire investor's hedge fund Paulson &amp; Co. also holds a 37% stake in International Tower Hill Mines Ltd. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/THM#AMEX">THM</a>) and a $264.3 million stake in Perpetua Resources Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPTA#NASDAQ">PPTA</a>). 
Trilogy Metals Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TMQ#AMEX">TMQ</a>), Seabridge Gold, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SA#NYSE">SA</a>), Equinox Gold Corp. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EQX#AMEX">EQX</a>) and Iamgold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAG#NYSE">IAG</a>) round out the remainder of the firm&#8217;s miner holdings. 
Paulson has been building his miners portfolio for many years and is well-positioned to benefit from the soaring price of gold.&nbsp;
Gold Rally: Gold has surged more than 30% in 2025, reaching $3,490 per ounce on Tuesday and setting a new record high price. 
In fact, Monday's 3%-plus gold rally was the fifth time in the past 10 trading days that gold climbed at least 2% in a single day. The only periods that experienced a higher frequency of 2%-plus daily moves in the past 50 years were in January and June 1980, according to Bespoke Investment Group.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/04/44903087/amazon-stock-downgraded-price-target-slashed-as-tariffs-create-uncertainty">Amazon Stock Downgraded, Price Target Slashed As Tariffs Create Uncertainty&nbsp;</a></li>
</ul>
Photo: Shutterstock

Hedge Funds

Commodities

Markets

Movers

GOLD

PPTA

Billionaire John Paulson Buys $800 Million Stake In Alaskan Gold Mine As Gold Hits Record Highs

The price of gold blew past the $3,000 mark in early trading Friday as investors navigate market turbulence driven by escalating trade tensions and economic uncertainty. Billionaire hedge funder John Paulson has stacked his <a href="https://www.benzinga.com/25/03/44325928/gold-smashes-through-3000-mark-as-markets-brace-for-turbulence-and-fed-signals">portfolio with gold miners.&nbsp;</a>
According to Paulson &amp; Company's latest 13F filing, the fund increased its position in International Tower Hill Mines Ltd. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/THM#AMEX">THM</a>) in the fourth quarter, adding over six million shares. The recent buys brought Paulson's total holdings to more than 70 million shares and a 37% stake in the mining company. 
Read Next: <a href="https://www.benzinga.com/government/regulations/25/03/44310724/doge-cuts-to-ftc-sow-confusion-in-case-against-amazon">DOGE Cuts To FTC Sow Confusion In Case Against Amazon</a>&nbsp;
International Tower Hills Mines holds interests in the Livengood Gold Project, located northwest of Fairbanks, Alaska, in the Tolovana mining district within the Tintina gold belt. The company's stock has climbed more than 40% over the past month as the price of gold rallied. 
Other Miner Holdings: Paulson &amp; Co.&#8217;s other gold miner holdings include a $264.3 million stake in Perpetua Resources Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPTA#NASDAQ">PPTA</a>) and a $111 million stake in Novagold Resources Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NG#AMEX">NG</a>). 
Trilogy Metals Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TMQ#AMEX">TMQ</a>), Seabridge Gold, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SA#NYSE">SA</a>), Equinox Gold Corp. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EQX#AMEX">EQX</a>) and Iamgold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAG#NYSE">IAG</a>) round out the remainder of Paulson&#8217;s gold mining holdings. 
Paulson talked about de-dollarization and the benefits of owning gold in a 2023 <a href="https://www.alainelkanninterviews.com/john-paulson/">interview</a> with Alain Elkann.&nbsp;
"There has been a significant increase in demand from central banks to replace dollars with gold, and we're just at the beginning of that trend. Gold will go up and the dollar will go down, so you'd be better off keeping your investment reserves in gold at this point," Paulson said.&nbsp;
The SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) ETF, which tracks the price of gold bullion, has gained nearly 40% over the past year.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/03/44253259/uncertainty-rocks-the-trump-trade-how-maga-seven-stocks-look-now">Uncertainty Rocks The Trump Trade: How &#8216;MAGA Seven&#8217; Stocks Look Now</a></li>
</ul>
Image: Shutterstock&nbsp;

Equities

Billionaire Hedge Funder Adds Mining Stocks Before Gold Makes Record-Highs: 'Gold Will Go Up,' Paulson Says

Billionaire hedge fund manager John Paulson appears to be bullish on gold miners as his fund, Paulson &amp; Co., holds <a href="https://www.benzinga.com/24/12/42598636/gold-falls-sharply-lamb-weston-shares-plunge">several mining stocks.&nbsp;</a>
What To Know: Paulson is well-known for betting against the housing market in 2006 and profiting about $20 billion when subprime mortgage bonds collapsed. He has been gathering gold mining stocks for years and with the price of gold <a href="https://www.benzinga.com/government/24/09/41043392/harris-vows-to-push-america-forward-stockpile-critical-minerals">climbing more</a> than 29% in 2024, investors may be interested in which companies Paulson &amp; Co. holds.&nbsp;
Read More: <a href="https://www.benzinga.com/general/social-media/24/12/42598651/mystery-drone-sightings-all-over-the-country-trump-says-what-to-know-about-investigations-lawmakers-reactions">&#8216;Mystery Drone&#8217; Sightings Spark Investigations, Politicians Respond: &#8216;Shoot Them Down,&#8217; Trump Says</a>
Paulson's Holdings: The Paulson &amp; Co. fund is heavily invested in mining stocks which together make up more than 33% of the total portfolio. Paulson's other holdings include mostly shares of healthcare and financial services companies.&nbsp;
According to the fund's most recent 13F<a href="https://www.sec.gov/Archives/edgar/data/0001035674/000101359424000980/xslForm13F_X02/primary_doc.xml"> filing</a>, Paulson &amp; Co.'s largest gold miner holding is a $231.6 million stake in Perpetua Resources Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPTA#NASDAQ">PPTA</a>), a development-stage mining company primarily focused on the exploration and restoration of the Stibnite Gold Project in Idaho.&nbsp;
Perpetua Resources stock is up nearly 300% in 2024.&nbsp;
The fund also holds a $111 million stake in Novagold Resources Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NG#AMEX">NG</a>) which owns 50% of the Donlin Gold project located in southwestern Alaska.&nbsp;
International Tower Hill Mines, Ltd. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/THM#AMEX">THM</a>), a gold miner with mines in Canada, Mexico, Finland, and Australia, is one of two penny stock holdings found in Paulson's fund. The other is Trilogy Metals Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TMQ#AMEX">TMQ</a>) with mineral resource properties including the Upper Kobuk Mineral Projects in Alaska.&nbsp;
Seabridge Gold, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SA#NYSE">SA</a>), Equinox Gold Corp. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EQX#AMEX">EQX</a>) and Iamgold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAG#NYSE">IAG</a>) round out the remainder of Paulson's gold mining holdings. 
Notably, the fund closed its position in AngloGold Ashanti Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>), selling nearly 2 million shares in the third quarter of 2024.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42564443/santa-came-early-with-rate-cut-but-federal-reserve-brings-coal-next-year-experts-weigh-in-on-rate-cut-feds-2025-projections">&#8216;Santa Came Early&#8217; But Fed Brings &#8216;Coal Next Year&#8217;: Experts Weigh In On Interest Rate Cut, 2025 Projections</a></li>
</ul>
Image: Shutterstock

Billionaire John Paulson Bullish On Gold Miners, Including This Penny Stock

Intl Tower Hill Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/THM#AMEX">THM</a>) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year.

Intl Tower Hill Mines Q2 EPS $(0.01), Same YoY

&nbsp;International Tower Hill Mines Ltd. (the "Company") - (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ITH#TSX">ITH</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THM#NYSE">THM</a>) today announced that it has completed a non-brokered private placement (the "Private Placement") pursuant to which it has issued common shares to existing major shareholders to raise gross proceeds of approximately USD $2.5 million.
The Private Placement consisted of 3,807,911 common shares of the Company, representing approximately 1.9% of the 195.9 million common shares issued and outstanding prior to the completion of the Private Placement, at a price of USD$0.664 per common share, the closing price of the Company's common shares on the NYSE American on January 12, 2024.&nbsp; The Private Placement was taken up by current institutional shareholders of the Company, Paulson &amp; Co. Inc., Sprott Asset Management USA, Inc., and Kopernik Global Investors, LLC on behalf of Heptagon plc Kopernik Global All-Cap Equity Fund. The Company intends to use the net proceeds of the Private Placement for general working capital purposes. Following completion of the Private Placement, the Company has 199,693,442 common shares issued and outstanding.
Karl Hanneman, Chief Executive Officer, said "This modest financing was completed with respect for our current shareholders to minimize dilution and reflects our low G&amp;A expenses as we position the Livengood Gold Project to respond to a strong gold market.&nbsp; We remain appreciative of our major shareholders who recognize the great leverage that the Livengood Gold Project offers in a rising gold market, given the size of the gold resource, its unique and positive fundamentals, and our land status and proximity to Fairbanks."
The Private Placement has received the required regulatory approvals including approval of the Toronto Stock Exchange and the NYSE American. All common shares issued in the Private Placement are subject to a hold period in Canada of four months and one day from the closing of the Private Placement. All common shares issued in the United States will be subject to resale restrictions under U.S. federal and state securities laws.
As certain of the institutional shareholders qualify as related parties of the Company, the Private Placement was a "related party transaction" within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company is relying upon exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 on the basis that the fair market value of the shares issued to such shareholders does not exceed 25% of the Company's current market capitalization.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the common shares issued in the Private Placement, nor shall there be any offer or sale of the common shares issued in the Private Placement in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

Offerings

TSX:ITH

International Tower Hill Mines Announces $2.5M Non-Brokered Private Placement

In the latest virtual conference presented by Benzinga, three outstanding experts and industry professionals gathered to explore the prospects of a new <a href="https://www.benzinga.com/events/#virtual-events">&#8220;Supercycle&#8221; for gold miners. </a>
Delving into crucial factors affecting the performance of gold mining stocks, they discussed Fed interest rates, market valuations, geopolitics, ESG and technological innovation in the industry. 
In the first part, Imaru Casanova, a portfolio manager for Gold and Precious Metals at VanEck, highlighted the potential bullish catalysts for gold miners and presented her top stock recommendations. 
Taylor McKenna, CFA and an analyst at Kopernik Global Investors, emphasized the value of gold mining stocks and discussed the application of AI technologies. 
Luke Norman, co-founder and executive chairman at US Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USAU#NYSE">USAU</a>), offered insights into the gold mining exploration side and the permitting cycle.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Benzinga Virtual Event: A New Supercycle for Gold Miners?" width="500" height="281" src="https://www.youtube.com/embed/i4aLbrAoe1I?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen></iframe>
</div>
</figure>
<h2 class="wp-block-heading">VanEck Sees Attractive Valuations In The Gold Mining Industry</h2>
VanEck&#8217;s Casanova expressed optimism about the outlook for gold miners, citing the end of the Fed tightening cycle as a potential bullish catalyst. 
With strong global support in the current environment, gold miners are poised to demonstrate their leverage with higher gold prices. Casanova highlighted the historically low multiples at which gold mining stocks are currently trading, coupled with controlled balance sheet costs, generate an attractive investment opportunity.
&#8220;When gold traded at these levels (around $1,970) in the past, stocks in the VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>) or VanEck Junior Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDXJ#NYSE">GDXJ</a>) index were trading 15-20% higher,&#8221; Casanova said. 
Regarding top stock recommendations, Casanova identified Endeavor Mining PLC (OTCPK: EDVMF), Alamos Gold Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGI#NYSE">AGI</a>), and Agnico Eagle Mines Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEM#NYSE">AEM</a>). She emphasized that VanEck&#8217;s current price forecast for gold is $2,075 per ounce in the next 12 months, which offers a compelling case for diversification and growth in the gold mining sector.
Read Also: <a href="https://www.benzinga.com/news/23/07/33287887/agnico-eagle-mines-debt-overview">Agnico Eagle Mines&#8217; Debt Overview</a>
<h2 class="wp-block-heading">Kopernik Global Investors Is Bullish On Smaller Miners </h2>
Kopernik Global Investors&#8217; McKenna expressed strong conviction in gold mining, pointing out the attractive valuations the sector offers. McKenna discussed the opportunity in smaller companies within the industry such as Seabridge Gold Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SA#NYSE">SA</a>), International Tower Hill Mines Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THM#NYSE">THM</a>), and Western Copper and Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRN#NYSE">WRN</a>), which trade at even cheaper valuations than big miners but carry higher risk.
Among the majors he highlighted is Barrick Gold Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>) offers attractive valuations as it shows an all-in-sustaining cost (AISC) of $1,400 an ounce, positioning the company for significant potential if gold prices continue to rise.
McKenna also stressed the importance of scrutinizing management teams and incentives, and he shared insights into how AI technologies, such as driverless trucks for mining, are being employed to boost productivity and reduce environmental impact.
<h2 class="wp-block-heading">US Gold Corp&#8217;s Vision for the Greenest Mine in North America</h2>
US Gold Corp.&#8217;s Norman shed light on the gold mining exploration and permitting cycle. He emphasized that smaller companies involved in gold exploration often become investment vehicles for larger corporations in the sector. Norman provided an overview of US Gold Corp.&#8217;s primary project, the CK Gold project, and its location just outside Cheyenne, Wyoming.
&#8220;Navigating the permitting process in North America can be challenging, with federal agencies causing bottlenecks,&#8221; Norman said. 
Norman did highlight the advantage of working with the state of Wyoming, which has set a mandate for a more streamlined permitting timeline. 
Despite trading at a significant market discount due to perceived permitting challenges, US Gold Corp. has 1.5 million ounces of reserves in the ground, and its all-in-sustaining costs are projected at $800 per ounce. 
Norman believed the in-situ value of reserves in the ground should place U.S. Gold Corp&#8217;s market cap to about $300 million, while the company is currently trading at about $40 million market cap. Norman highlighted how ESG became a hugely important factor in the business and he aspired to develop the greenest mine in North America.
<a href="https://www.benzinga.com/quote/USAU/analyst-ratings">Now Read: U.S. Gold Stock, Analyst Ratings, Price Targets, Predictions</a>
Photo: Shutterstock

Analyst Color

Government

Large Cap

Long Ideas

Regulations

Sector ETFs

Small Cap

Exclusives

Analyst Ratings

Trading Ideas

ETFs

EDVMF

Market Vectors ETF Trust Market Vectors Gold Miners

GDXJ

USAU

Unlocking Gold Mining's Supercycle: Insights From Benzinga's Virtual Conference

Allen David Cross, Chief Financial Officer at Intl Tower Hill Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/THM#AMEX">THM</a>), reported a large acquisition of company stock options on May 25, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001134115/000106299323012233//Archives/edgar/data/1134115/000106299323012233/0001062993-23-012233-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Cross, Chief Financial Officer at Intl Tower Hill Mines, a company in the Materials sector, was just awarded stock options worth 15,000 shares of THM. The options give Cross the right to buy the company's stock at $0.47 per share.
Intl Tower Hill Mines shares are trading up 3.12% at $0.49 at the time of this writing on Friday morning. Since the current price is $0.49, this makes Cross's 15,000 shares worth $7,347.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Transaction Codes To Focus On</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001134115">Check Out The Full List Of Intl Tower Hill Mines's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Intl Tower Hill Mines Chief Financial Officer Awarded $7K Worth of Stock Options

Karl Hanneman, Chief Executive Officer at Intl Tower Hill Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/THM#AMEX">THM</a>), reported a large acquisition of company stock options on May 25, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001134115/000106299323012231//Archives/edgar/data/1134115/000106299323012231/0001062993-23-012231-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Hanneman, Chief Executive Officer at Intl Tower Hill Mines, a company in the Materials sector, was just awarded stock options worth 150,000 shares of THM. The options give Hanneman the right to buy the company's stock at $0.47 per share.
Intl Tower Hill Mines shares are trading up 3.12% at $0.49 at the time of this writing on Friday morning. Since the current price is $0.49, this makes Hanneman's 150,000 shares worth $73,470.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001134115">Check Out The Full List Of Intl Tower Hill Mines's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Chief Executive Officer at Intl Tower Hill Mines Acquires Company Stock Options Worth 150,000 Shares

B. Riley Securities analyst Lucas Pipes maintains Intl Tower Hill Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/THM#AMEX">THM</a>) with a Buy and lowers the price target from $5 to $2.

Price Target

B. Riley Securities Maintains Buy on Intl Tower Hill Mines, Lowers Price Target to $2

<h3>Gainers</h3>
<ul>
<li>AMTD Digital Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hkd#NYSE">HKD</a>) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.</li>
<li>SKYX Platforms Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skyx#NASDAQ">SKYX</a>) jumped 43.2% to close at $4.91.</li>
<li>Qudian Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/qd#NYSE">QD</a>) gained 40.3% to close at $1.67 after the company highlighted progress in its QD Food brand and said its 717 Foodies Festival fueled sales of approximately 9.56 million dishes.</li>
<li>Intelligent Living Application Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ilag#NASDAQ">ILAG</a>) shares gained 37.8% to close at $3.10 on Monday after declining 11% on Friday. The company reported closing of $20.24 million initial public offering.</li>
<li>Exela Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xela#NASDAQ">XELA</a>) rose 34.3% to close at $0.1350.</li>
<li>Troika Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) gained 31.5% to close at $0.8040.</li>
<li>Tantech Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tanh#NASDAQ">TANH</a>) jumped 23.1% to close at $0.32 after the company posted a narrower FY loss.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxi#NASDAQ">ATXI</a>) shares gained 22.7% to settle at $0.3220.</li>
<li>EZFill Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezfl#NASDAQ">EZFL</a>) surged 22.5% to settle at $0.79.</li>
<li>Boxed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boxd#NYSE">BOXD</a>) rose 21.7% to close at $2.19.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) gained 21.4% to close at $9.76 in sympathy with the price of Bitcoin.</li>
<li>International Tower Hill Mines Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/thm#NYSE">THM</a>) jumped 20.3% to close at $0.6255.</li>
<li>Trio-Tech International (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trt#NYSE">TRT</a>) gained 19.2% to close at $5.18.</li>
<li>North European Oil Royalty Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nrt#NYSE">NRT</a>) jumped 19.1% to settle at $14.55. Shares of energy companies traded higher amid a gain in oil prices due to supply concerns after President Biden was unable to secure a commitment from Saudi Arabia for increased output.</li>
<li>Dingdong (Cayman) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddl#NYSE">DDL</a>) shares gained 18% to settle at $6.03. Dingdong, last month, said Q1 sales results were up 43.2% year over year.</li>
<li>Calyxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clxt#NASDAQ">CLXT</a>) rose 17.6% to close at $0.2410.</li>
<li>Lucira Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lhdx#NASDAQ">LHDX</a>) jumped 17.1% to close at $3.01.</li>
<li>SkyWater Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skyt#NASDAQ">SKYT</a>) gained 16.4% to settle at $8.94.</li>
<li>Clear Channel Outdoor Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cco#NYSE">CCO</a>) rose 16% to settle at $1.23.</li>
<li>Inotiv, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/notv#NASDAQ">NOTV</a>) rose 15.9% to close at $12.38 as the company said Envigo has reached an agreement with the US Department of Justice and US Department of Agriculture to resolve civil and administrative complaints.</li>
<li>Puhui Wealth Investment Management Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phcf#NASDAQ">PHCF</a>) gained 15.9% to close at $0.8768.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) rose 15.6% to close at $2.59 following last week&#39;s reports suggesting Senate Democrats will roll out a decriminalization bill this week.</li>
<li>GAN Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gan#NASDAQ">GAN</a>) gained 15.6% to close at $3.33.</li>
<li>Capstone Green Energy Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgrn#NASDAQ">CGRN</a>) rose 15.4% to close at $1.84. Capstone Green Energy&rsquo;s Alaska distributor Artic Energy has secured a new 12-month Energy-as-a-Service (EaaS) rental contract with a local oil and gas company headquartered in Anchorage.</li>
<li>Expion360 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xpon#NASDAQ">XPON</a>) gained 14.9% to close at $2.55.</li>
<li>Creative Medical Technology Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celz#NASDAQ">CELZ</a>) jumped 14.4% to close at $0.73.</li>
<li>Startek, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/srt#NYSE">SRT</a>) gained 14.3% to close at $3.27.</li>
<li>ProKidney Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prok#NASDAQ">PROK</a>) gained 13.3% to close at $7.95 after dropping 20% on Friday.</li>
<li>Rain Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rain#NASDAQ">RAIN</a>) rose 12.8% to close at $6.42.</li>
<li>Expensify, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exfy#NASDAQ">EXFY</a>) gained 12.3% to close at $19.66 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $20 to $25.</li>
<li>Advent Technologies Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adn#NASDAQ">ADN</a>) shares rose 12.2% to settle at $2.95 after the company&#39;s Green HiPo project received official ratification from the European Commission.</li>
<li>The ODP Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/odp#NASDAQ">ODP</a>) gained 12.1% to close at $35.32 after the company issued preliminary Q2 results and announced a $600 million buyback.</li>
<li>Verve Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verv#NASDAQ">VERV</a>) climbed 11% to close at $26.31. BMO Capital maintained Verve Therapeutics with an Outperform and raised the price target from $48 to $62.</li>
<li>Hut 8 Mining Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hut#NYSE">HUT</a>) climbed 10.8% to close at $1.75. Shares of cryptocurrency-related stocks traded higher amid a rise in the price of Bitcoin.</li>
<li>Rayonier Advanced Materials Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ryam#NYSE">RYAM</a>) gained 9.9% to close at $3.10 after RBC Capital upgraded the stock from Sector Perform to Outperform.</li>
<li>Grab Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grab#NASDAQ">GRAB</a>) gained 9.6% to close at $2.73 after analysts at JP Morgan upgraded their rating of the stock from Neutral to Overweight.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) rose 9.1% to settle at $58.67. Coinbase Global has secured approval from Italian regulators to provide ongoing crypto services to its resident, the cryptocurrency exchange stated in a blog post.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) gained 9% to close at $4.36.</li>
<li>Eton Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eton#NASDAQ">ETON</a>) climbed 8.6% to settle at $3.03. The FDA has approved Eton Pharmaceuticals&rsquo; Zonisade (zonisamide oral suspension) for partial seizures in patients with epilepsy.</li>
<li>Core Scientific, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/corz#NASDAQ">CORZ</a>) gained 8.3% to close at $1.69.</li>
<li>KE Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/beke#NYSE">BEKE</a>) shares climbed 6.9% to settle at $14.94.</li>
<li>Bitfarms Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bitf#NASDAQ">BITF</a>) rose 6.8% to close at $1.25 amid a rise in the price of Bitcoin.</li>
<li>Phoenix New Media Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/feng#NYSE">FENG</a>) gained 6.6% to settle at $5.33. Phoenix New Media, last month, announced it has regained compliance with the NYSE&#39;s continued listing standard for share prices.</li>
<li>LumiraDx Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmdx#NASDAQ">LMDX</a>) rose 5.5% to close at $2.48 after dropping around 10% on Friday. LumiraDx, last month, announced it achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2 STAR Complete and SARS-CoV-2 &amp; Flu A/B RNA STAR Complete.</li>
<li>Carnival Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccl#NYSE">CCL</a>) gained 5.1% to close at $9.65 amid overall market strength. Better-than-expected Q2 earnings from Goldman Sachs have lifted market sentiment following recent macro concerns, which have pressured the travel sector this year.</li>
</ul>
&nbsp;
<h3>Losers</h3>
<ul>
<li>United Maritime Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/usea#NASDAQ">USEA</a>) shares dipped 58.7% to close at $2.51 on Monday after the company reported pricing of $26 million offering.</li>
<li>Performance Shipping Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pshg#NASDAQ">PSHG</a>) fell 57.1% to settle at $0.2349 after the company announced a $5.95 million registered direct offering priced at $0.35 per share.</li>
<li>Gorilla Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grrr#NASDAQ">GRRR</a>) dropped 46% to settle at $19.55.</li>
<li>G Medical Innovations Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmvd#NASDAQ">GMVD</a>) fell 45.1% to close at $0.5106.</li>
<li>Sesen Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sesn#NASDAQ">SESN</a>) declined 31.6% to close at $0.6157. Based on a thorough reassessment, Sesen Bio has decided to voluntarily pause further development in the U.S. of its lead asset, Vicineum, for non-muscle invasive bladder cancer.</li>
<li>ITHAX Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ithx#NASDAQ">ITHX</a>) fell 27.6% to settle at $10.13. ITHAX Acquisition&rsquo;s shareholders recently approved business combination with Mondee.</li>
<li>GlucoTrack, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gctk#NASDAQ">GCTK</a>) declined 25.2% to close at $2.02.</li>
<li>Lion Group Holding Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lghl#NASDAQ">LGHL</a>) dipped 23.7% to close at $1.13.</li>
<li>HTG Molecular Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htgm#NASDAQ">HTGM</a>) fell 20.1% to close at $1.51.</li>
<li>Kalera Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kal#NASDAQ">KAL</a>) dipped 18.4% to close at $4.07.</li>
<li>Skillful Craftsman Education Technology Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edtk#NASDAQ">EDTK</a>) fell 17.6% to close at $0.8410.</li>
<li>MacroGenics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgnx#NASDAQ">MGNX</a>) fell 16.9% to close at $3.50.</li>
<li>Anavex Life Sciences Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avxl#NASDAQ">AVXL</a>) dipped 16.5% to close at $10.60.</li>
<li>Hillstream BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hils#NASDAQ">HILS</a>) fell 16.3% to settle at $1.03.</li>
<li>Shineco, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sisi#NASDAQ">SISI</a>) fell 15.7% to close at $1.18.</li>
<li>Datasea Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dtss#NASDAQ">DTSS</a>) fell 15.7% to close at $1.83. Datasea subsidiary Guohao Century (Beijing) Technology Ltd inked a purchase agreement with Hangzhou Runsheng Network Technology Ltd, a leading marketing service provider, for a consideration of $22.3 million (RMB 150 million).</li>
<li>Lottery.com Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltry#NASDAQ">LTRY</a>) fell 15.1% to close at $0.8202. Lottery.com said in connection with appointment of Interim CFO, the company initiated review of cash balances and related disclosures, leading the company to preliminarily conclude it has overstated available unrestricted cash balance by about $30 million.</li>
<li>Tuesday Morning Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tuem#NASDAQ">TUEM</a>) fell 13.9% to close at $0.3334.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmn#NASDAQ">PMN</a>) dropped 13.8% to close at $5.67.</li>
<li>Mawson Infrastructure Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/migi#NASDAQ">MIGI</a>) fell 13.6% to close at $0.8728 after the company announced a $6.4 million registered direct offering.</li>
<li>Cemtrex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cetx#NASDAQ">CETX</a>) fell 12.8% to close at $0.3550 after jumping over 30% on Friday.</li>
<li>Aerovate Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avte#NASDAQ">AVTE</a>) fell 12.4% to close at $15.76.</li>
<li>Achilles Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/achl#NASDAQ">ACHL</a>) fell 11.7% to close at $2.34. Achilles Therapeutics recently reported the appointment of James Taylor as Chief Business Officer and Cassian Yee, MD to its Scientific Advisory Board.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) fell 11.5% to close at $1.62.</li>
<li>BlackLine, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bl#NASDAQ">BL</a>) fell 10.4% to settle at $15.76 after B of A Securities downgraded the stock from Neutral to Underperform and lowered its price target from $75 to $64.</li>
<li>Seagen Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgen#NASDAQ">SGEN</a>) dropped 5.7% to close at $168.47. Weakness was possibly due to a Friday WSJ report suggesting Merck&#39;s deal for the company will likely not be finalized by Merck&#39;s earnings release.</li>
<li>The Progressive Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pgr#NYSE">PGR</a>) shares declined 5% to settle at $110.29. Progressive, on Friday, reported better-than-expected Q2 EPS results.</li>
<li>Nymox Pharmaceutical Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nymx#NASDAQ">NYMX</a>) fell 5% to close at $0.2850 after surging around 39% on Friday.</li>
</ul>

Penny Stocks

Pre-Market Outlook

ACHL

ATXI

AVTE

AVXL

BEKE

BITF

BOXD

CELZ

CETX

CGRN

CLXT

COIN

Core Scientific, Inc. - Class A Common Stock

CORZ

DTSS

EDTK

ETON

EXFY

EZFL

FENG

GCTK

GMVD

GRAB

GRRR

HILS

HTGM

ILAG

ITHX

LGHL

LHDX

LMDX

LTRY

MARA

MGNX

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

NEXI

NOTV

NYMX

PHCF

PROK

PSHG

RAIN

RYAM

SESN

SGEN

SISI

SKYT

SKYX

TANH

TRKA

TUEM

USEA

VERV

XELA

XPON

Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday

<h3>Gainers</h3>
<ul>
<li>Inspirato Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ispo#NASDAQ">ISPO</a>) shares climbed 618.2% to close at $92.65 on Thursday, just a few days after the company completed its SPAC merger with Thayer Ventures.</li>
<li>Cepton, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cptn#NASDAQ">CPTN</a>) surged 343.5% to close at $42.00.</li>
<li>Anghami Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/angh#NASDAQ">ANGH</a>) jumped 161.4% to close at $28.88 amid continued volatility following its recent listing on Nasdaq.</li>
<li>Flotek Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftk#NYSE">FTK</a>) rose 70.2% to settle at $1.35 as the company was awarded a $1 billion long term contract.</li>
<li>Quanergy Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/qngy#NYSE">QNGY</a>) surged 30.9% to close at $4.19.</li>
<li>Nuvectis Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvct#NASDAQ">NVCT</a>) gained 21.2% to settle at $6.75 amid post-IPO volatility.</li>
<li>Bellicum Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blcm#NASDAQ">BLCM</a>) jumped 19.5% to close at $1.90. Ladenburg Thalmann initiated coverage on Bellicum Pharmaceuticals with a Buy rating and announced a price target of $5.</li>
<li>International Tower Hill Mines Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/thm#NYSE">THM</a>) jumped 19.5% to settle at $1.07.</li>
<li>IBEX Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibex#NASDAQ">IBEX</a>) gained 19.5% to close at $16.57 after the company reported better-than-expected Q2 sales results and raised FY22 organic sales growth guidance. The company also reported a $20 million share buyback.</li>
<li>Grindrod Shipping Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grin#NASDAQ">GRIN</a>) jumped 19.4% to settle at $25.07.</li>
<li>China HGS Real Estate Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgsh#NASDAQ">HGSH</a>) gained 18.8% to close at $2.78.</li>
<li>U.S. Xpress Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/usx#NYSE">USX</a>) jumped 18.4% to settle at $4.11 on Thursday. The company&rsquo;s Director John Rickel acquired a total of 30,000 shares at an average price of $3.68.</li>
<li>Fast Radius, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fsrd#NASDAQ">FSRD</a>) rose 16.9% to settle at $3.80.</li>
<li>COMSovereign Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coms#NASDAQ">COMS</a>) surged 16.6% to close at $0.6999.</li>
<li>Rhythm Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rytm#NASDAQ">RYTM</a>) gained 16.1% to close at $7.70 after Ladenburg Thalmann upgraded the stock from Neutral to Buy and announced a $15 price target.</li>
<li>Marin Software Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrin#NASDAQ">MRIN</a>) surged 15% to settle at $3.76 after the company announced TikTok integration.</li>
<li>Global-e Online Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glbe#NASDAQ">GLBE</a>) shares gained 14.7% to close at $42.33 after the company reported Q4 adjusted EBITDA results were higher year over year and better-than-expected Q4 sales results. The company also issued Q1 and FY22 sales guidance above estimates.</li>
<li>BRC Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brcc#NYSE">BRCC</a>) gained 14.7% to close at $18.13.</li>
<li>KAR Auction Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kar#NYSE">KAR</a>) gained 14.3% to settle at $14.13 following upbeat quarterly results.</li>
<li>Outset Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/om#NASDAQ">OM</a>) gained 13.8% to close at $38.94 as the company recorded Q4 FY21 net revenue of $28.2 million, a 63.2%, beating the consensus of $26.42 million.</li>
<li>Visteon Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vc#NASDAQ">VC</a>) gained 12.7% to settle at $118.79 following upbeat Q4 results..</li>
<li>ACV Auctions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acva#NASDAQ">ACVA</a>) gained 12.6% to close at $12.52 after the company posted upbeat quarterly results.</li>
<li>DoorDash, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dash#NYSE">DASH</a>) climbed 10.7% to close at $105.03 after the company reported better-than-expected Q4 sales results.</li>
<li>Assertio Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asrt#NASDAQ">ASRT</a>) rose 8.9% to close at $2.58.</li>
<li>Baudax Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bxrx#NASDAQ">BXRX</a>) gained 8.3% to close at $4.98. The company recently reported a 1-for-35 reverse stock split.</li>
<li>TriNet Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tnet#NYSE">TNET</a>) surged 8% to close at $87.74. TriNet Group commenced modified dutch auction tender offer to repurchase up to $300 million of its common stock.</li>
<li>UFP Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ufpi#NASDAQ">UFPI</a>) gained 6.1% to close at $84.31 following Q4 results.</li>
</ul>

<a href="https://www.benzinga.com/trading-ideas/long-ideas/22/02/25683373/u-s-xpress-enterprises-and-4-other-penny-stocks-bought-by-insiders">Also check out: U.S. Xpress Enterprises And 4 Other Penny Stocks Bought By Insiders</a>
<h3>Losers</h3>
<ul>
<li>Amplitude, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampl#NASDAQ">AMPL</a>) shares dipped 58.9% to close at $17.10 on Thursday after the company reported Q4 earnings results and issued Q1 and FY22 sales guidance below estimates.</li>
<li>Guardion Health Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ghsi#NASDAQ">GHSI</a>) fell 34.1% to close at $0.37 after the company announced a proposed public offering of common stock.</li>
<li>Fastly, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsly#NYSE">FSLY</a>) fell 33.6% to settle at $19.20 after the company reported Q4 earnings results and issued Q1 and FY22 guidance.</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) dropped 31.3% to close at $1.84. Smart for Life priced its 1.44 million unit IPO at $10 per share.</li>
<li>Meihua International Medical Technologies Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mhua#NASDAQ">MHUA</a>) fell 30.3% to close at $9.00. Meihua International Medical Technologies priced its 3.6 million share IPO at $10 per share.</li>
<li>Informatica Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/infa#NYSE">INFA</a>) fell 28.3% to close at $20.18 after the company reported downbeat quarterly earnings.</li>
<li>Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) dropped 27.4% to close at $1.62. Roth Capital initiated coverage on the stock with a Buy rating and a $12 price target.</li>
<li>Marker Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrkr#NASDAQ">MRKR</a>) dropped 26% to close at $0.4570 after Roth Capital downgraded the company from Buy to Neutral and lowers the price target from $3 to $1. The company reported initial results from the Phase 2 trial for MT-401 as a treatment option for Acute myeloid leukemia (AML) in the post-transplant setting.</li>
<li>WalkMe Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wkme#NASDAQ">WKME</a>) dipped 25.5% to close at $12.73 following Q4 results.</li>
<li>Ribbon Communications Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rbbn#NASDAQ">RBBN</a>) dipped 22.7% to close at $3.50 after the company reported worse-than-expected Q4 EPS and sales results. The company also issued FY22 adjusted EPS and sales guidance below estimates.</li>
<li>Color Star Technology Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cscw#NASDAQ">CSCW</a>) shares fell 21.4% to close at $0.5815 after declining 17% on Wednesday. The company announced its Color World Metaverse Software has gone live in the Android app store.</li>
<li>Paymentus Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pay#NYSE">PAY</a>) fell 21.3% to close at $23.87 following Q4 results.</li>
<li>Albemarle Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alb#NYSE">ALB</a>) fell 19.9% to close at $197.02 after the company reported worse-than-expected Q4 sales results.</li>
<li>Hillstream BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hils#NASDAQ">HILS</a>) dipped 19.9% to settle at $1.97. Hillstream BioPharma recently received orphan drug designation for its HSB-1216 for the treatment of uveal melanoma.</li>
<li>Modiv Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mdv#NYSE">MDV</a>) fell 19.8% to close at $20.62. The company recently priced its IPO at $25 per share.</li>
<li>Bakkt Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bkkt#NYSE">BKKT</a>) fell 19.4% to settle at $6.32 after the company reported Q4 earnings results.</li>
<li>Altice USA, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atus#NYSE">ATUS</a>) dropped 17.9% to close at $11.83 after the company reported Q4 earnings results.</li>
<li>Matterport, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mttr#NASDAQ">MTTR</a>) fell 17.4% to close at $6.54 after the company reported worse-than-expected Q4 EPS results and issued Q1 and FY22 adjusted EPS and sales guidance below estimates.</li>
<li>GBS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbs#NASDAQ">GBS</a>) fell 17.1% to close at $0.5299. GBS recently reported worse-than-expected Q2 EPS results.</li>
<li>Trupanion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trup#NASDAQ">TRUP</a>) fell 17% to settle at $75.87 following Q4 results.</li>
<li>Scopus BioPharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/scps#NASDAQ">SCPS</a>) dipped 17% to close at $0.8301.</li>
<li>Permian Basin Royalty Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pbt#NYSE">PBT</a>) declined 17% to close at $11.57.</li>
<li>Coeur Mining, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cde#NYSE">CDE</a>) dropped 15.4% to settle at $4.52 following Q4 results.</li>
<li>Vivakor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vivk#NASDAQ">VIVK</a>) fell 15.1% to close at $2.42.</li>
<li>10x Genomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/txg#NASDAQ">TXG</a>) shares fell 14.7% to settle at $80.99 after the company reported worse-than-expected Q4 EPS and sales results and issued FY22 sales guidance below estimates.</li>
<li>LKQ Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lkq#NASDAQ">LKQ</a>) dropped 14.3% to close at $47.64 following Q4 results.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) fell 14.1% to settle at $2.08. The company recently priced its IPO at $5.50 per unit.</li>
<li>Brightcove Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcov#NASDAQ">BCOV</a>) fell 13.9% to settle at $7.78 after the company issued Q1 and FY22 EPS and sales guidance below estimates.</li>
<li>Sculptor Capital Management, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/scu#NYSE">SCU</a>) fell 13.5% to close at $13.86 following Q4 results.</li>
<li>Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) declined 12.8% to settle at $12.29 as the company posted Q4 net operating revenues of $3.23billion, a 3.7% Y/Y increase.</li>
<li>LianBio (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lian#NASDAQ">LIAN</a>) dipped 10% to close at $4.39.</li>
<li>AppLovin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/app#NASDAQ">APP</a>) fell 6.7% to close at $64.13 after the company reported worse-than-expected Q4 EPS results.</li>
<li>Strategic Education, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stra#NASDAQ">STRA</a>) fell 6.1% to close at $51.24.</li>
</ul>

<a href="https://www.benzinga.com/news/22/02/25689027/insiders-sell-more-than-92m-of-4-stocks">Also check out: Insiders Sell More Than $92M Of 4 Stocks</a>

ACVA

AMPL

ANGH

ASRT

ATUS

BCOV

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLCM

BRCC

BXRX

COMS

CPTN

CSCW

DASH

DRCT

FSLY

FSRD

GHSI

GLBE

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

HGSH

IBEX

INFA

ISPO

LIAN

MHUA

MRIN

MRKR

MTTR

NVCT

QNGY

RBBN

REVB

RYTM

SCPS

SMFL

STRA

TNET

TRUP

UFPI

VIVK

WKME

60 Biggest Movers From Yesterday

<h3>Gainers</h3>
<ul>
<li>Zogenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zgnx#NASDAQ">ZGNX</a>) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion.</li>
<li>G Medical Innovations Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmvd#NASDAQ">GMVD</a>) jumped 45.4% to close at $6.12. EH Hutton, on Tuesday, initiated coverage on the stock with a Buy rating and a $6 price target.</li>
<li>Valneva SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/valn#NASDAQ">VALN</a>) gained 45% to close at $47.52 after results from an initial laboratory study demonstrated that serum antibodies induced by three doses of Valneva&#39;s COVID-19 vaccine candidate, VLA2001, neutralize the omicron variant.</li>
<li>Vivos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvos#NASDAQ">VVOS</a>) surged 41.1% to settle at $2.30 after the company announced significant increases across several key metrics for its SleepImage Home Sleep Apnea Tests.</li>
<li>ShiftPixy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pixy#NASDAQ">PIXY</a>) gained 31.5% to close at $1.67.</li>
<li>NSTS Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nsts#NASDAQ">NSTS</a>) jumped 25.9% to close at $12.59 after the company priced its IPO at $10 per share.</li>
<li>Evofem Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evfm#NASDAQ">EVFM</a>) gained 22.9% to close at $0.4875. Evofem Biosciences achieved preliminary net product sales of $3.5 million in Q4 FY21, more than double in Q3 FY21.</li>
<li>Gamida Cell Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmda#NASDAQ">GMDA</a>) shares rose 22.5% to close at $2.72. Gamida Cell announced that following receipt of positive Type B meeting correspondence from the FDA. The company said it plans to initiate a rolling biologics license application submission for omidubicel, a potentially life-saving treatment for patients with blood cancers in need of stem cell transplant.</li>
<li>ReTo Eco-Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reto#NASDAQ">RETO</a>) gained 22% to settle at $2.16.</li>
<li>Splash Beverage Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbev#NASDAQ">SBEV</a>) rose 21.9% to settle at $3.96 after the company announced it has received authorization to sell its Pulpoloco Sangria line in 187 of Ralph&#39;s Grocery stores.</li>
<li>Muscle Maker, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gril#NASDAQ">GRIL</a>) gained 21.6% to close at $0.6290 after the company signed two additional franchise agreements in the Mississippi market.</li>
<li>Platinum Group Metals Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plg#NYSE">PLG</a>) surged 20.7% to settle at $1.98.</li>
<li>Aura Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aura#NASDAQ">AURA</a>) 19.9% to settle at $19.50.</li>
<li>Fresh Vine Wine, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vine#NYSE">VINE</a>) gained 19.6% to close at $6.70 after jumping around 9% on Tuesday. Fresh Vine Wine recently announced a partnership with CRAVE American Kitchen &amp; Sushi Bar.</li>
<li>Fusion Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fusn#NASDAQ">FUSN</a>) jumped 19.3% to close at $8.17. Fusion Pharmaceuticals recently announced a research collaboration with 48Hour Discovery to develop peptide-based radiopharmaceuticals.</li>
<li>New Pacific Metals Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newp#NYSE">NEWP</a>) gained 17.7% to close at $3.20.</li>
<li>WiMi Hologram Cloud Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wimi#NASDAQ">WIMI</a>) rose 16.7% to settle at $3.00.</li>
<li>Harmony Gold Mining Company Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hmy#NYSE">HMY</a>) gained 16.3% to close at $4.20.</li>
<li>International Tower Hill Mines Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/thm#NYSE">THM</a>) gained 15.8% to close at $0.8525.</li>
<li>Renren Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/renn#NYSE">RENN</a>) jumped 15.3% to close at $21.04.</li>
<li>SoFi Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sofi#NASDAQ">SOFI</a>) rose 13.7% to settle at $13.71. The San Francisco-based digital financial services company said Tuesday it had gained approvals from key regulators to become a full-fledged bank.</li>
<li>Reading International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdib#NASDAQ">RDIB</a>) gained 13.4% to close at $22.70.</li>
<li>Hecla Mining Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hl#NYSE">HL</a>) surged 11.8% to close at $5.78. HC Wainwright &amp; Co. recently maintained Hecla Mining with a Buy and lowered the price target from $7.5 to $7.25.</li>
<li>Endeavour Silver Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/exk#NYSE">EXK</a>) climbed 11.7% to settle at $4.67. Endeavour Silver recently announced plans to acquire The Pitarrilla Project for $70 million in cash and stock.</li>
<li>SilverCrest Metals Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/silv#NYSE">SILV</a>) gained 11.3% to close at $8.65.</li>
<li>Gatos Silver, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gato#NYSE">GATO</a>) gained 11.3% to close at $11.35. Gatos Silver recently said Q4 silver production up 35% from the previous quarter.</li>
<li>Kanzhun Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bz#NASDAQ">BZ</a>) rose 8.4% to close at $28.18.</li>
<li>Vaxxinity, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vaxx#NASDAQ">VAXX</a>) gained 7.9% to close at $7.94. Vaxxinity recently announced the first Parkinson&#39;s disease patient has been dosed in Part B of a Phase 1 clinical trial of UB-312.</li>
<li>Bird Global, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brds#NYSE">BRDS</a>) shares rose 6.6% to close at $3.73.</li>
</ul>
&nbsp;
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Cardiff Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdf#NASDAQ">CRDF</a>) shares fell 25.9% to close at $4.55 on Wednesday after the company posted new data from Phase 1b/2 trial of onvansertib combined with standard-of-care (SOC) FOLFIRI/bevacizumab for second-line KRAS-mutated metastatic colorectal cancer (mCRC).</li>
<li>OncoCyte Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocx#NASDAQ">OCX</a>) shares fell 24.2% to close at $2.0550. OncoCyte announced a development and co-marketing agreement for two distributed in vitro diagnostic assays on Thermo Fisher Scientific&rsquo;s Ion Torrent Genexus System.</li>
<li>Dingdong (Cayman) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddl#NYSE">DDL</a>) dipped 23.8% to settle at $6.10.</li>
<li>Petros Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptpi#NASDAQ">PTPI</a>) dropped 21.1% to close at $1.83. Petros Pharmaceuticals recently launcheed 2 self-selection studies for erectile dysfunction drug STENDRA.</li>
<li>Orion Energy Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oesx#NASDAQ">OESX</a>) dipped 17% to settle at $3.31 after the company lowered its FY22 sales forecast.</li>
<li>electroCore, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ecor#NASDAQ">ECOR</a>) fell 16.3% to close at $0.6901. ElectroCore filed for mixed shelf of up to $75 million.</li>
<li>Yumanity Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ymtx#NASDAQ">YMTX</a>) fell 16.1% to settle at $2.0550 after the company reported partial clinical hold by the US FDA on multidose clinical trials for YTX-7739.</li>
<li>Cerberus Cyber Sentinel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciso#NASDAQ">CISO</a>) shares dropped 16.1% to close at $4.22.</li>
<li>Kinnate Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/knte#NASDAQ">KNTE</a>) fell 15.7% to close at $12.85. Kinnate Biopharma announced FDA clearance of investigational drug application for KIN-3248.</li>
<li>Clearfield, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clfd#NASDAQ">CLFD</a>) dropped 15.6% to close at $55.66.</li>
<li>NeuroMetrix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nuro#NASDAQ">NURO</a>) fell 14.4% to close at $5.45. NeuroMetrix, on Tuesday, announced its Quell technology received Breakthrough Designation from the FDA for reducing moderate to severe symptoms of chemotherapy induced peripheral neuropathy.</li>
<li>PolarityTE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pte#NASDAQ">PTE</a>) dropped 14% to settle at $0.6174. PolarityTE recently announced the FDA has approved its investigational new drug application for the evaluation of SkinTE for the treatment of chronic cutaneous ulcers.</li>
<li>EQRx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eqrx#NASDAQ">EQRX</a>) fell 13.5% to close at $5.43. EQRx, along with its partner CStone Pharmaceuticals has announced data from Phase 3 GEMSTONE-302 trial of sugemalimab plus chemotherapy as a first-line treatment for stage IV non-small cell lung cancer (NSCLC).</li>
<li>Cardiol Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdl#NASDAQ">CRDL</a>) dipped 13.4% to close at $2.00.</li>
<li>Phunware, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) shares fell 12.9% to close at $2.83 after jumping over 12% on Tuesday.</li>
<li>Vinco Ventures, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbig#NASDAQ">BBIG</a>) dropped 12.7% to close at $4.53 after jumping over 27% on Tuesday.</li>
<li>Trio-Tech International (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trt#NYSE">TRT</a>) dipped 12.4% to close at $6.90.</li>
<li>Tritium DCFC Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcfc#NASDAQ">DCFC</a>) dropped 11% to close at $8.01.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ensc#NASDAQ">ENSC</a>) shares fell 10.4% to close at $3.10 after jumping more than 5% on Tuesday.</li>
<li>DatChat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dats#NASDAQ">DATS</a>) fell 10.2% to close at $2.99. DatChat shares jumped over 38% on Tuesday after the company announced it has initiated the development of a new platform that will leverage DatChat technology to share and protect NFTs, documents, audio and video files and messages.</li>
<li>Venus Concept Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vero#NASDAQ">VERO</a>) fell 9.8% to settle at $1.56. Venus Concept announced it received 510(k) clearance from the FDA to market the Venus BlissMAX device in the United States.</li>
<li>Immuron Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrn#NASDAQ">IMRN</a>) fell 9.2% to settle at $3.84.</li>
<li>Brickell Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbi#NASDAQ">BBI</a>) shares fell 7.3% to close at $0.3060. Brickell Biotech shares jumped over 58% on Tuesday after HC Wainwright &amp; Co initiated coverage on the stock with a Buy rating and $2 price target.</li>
</ul>

Comments

Intl Tower Hill Mines

Intl Tower Hill Mines (THM) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO